156 related articles for article (PubMed ID: 1586239)
1. Increased risk of cancer in patients with systemic lupus erythematosus.
Pettersson T; Pukkala E; Teppo L; Friman C
Ann Rheum Dis; 1992 Apr; 51(4):437-9. PubMed ID: 1586239
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.
Tallbacka KR; Pettersson T; Pukkala E
Scand J Rheumatol; 2018 Nov; 47(6):461-464. PubMed ID: 29318934
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.
Mellemkjaer L; Andersen V; Linet MS; Gridley G; Hoover R; Olsen JH
Arthritis Rheum; 1997 Apr; 40(4):761-8. PubMed ID: 9125261
[TBL] [Abstract][Full Text] [Related]
4. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
5. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
6. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
[TBL] [Abstract][Full Text] [Related]
7. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
8. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
9. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.
Björnådal L; Löfström B; Yin L; Lundberg IE; Ekbom A
Scand J Rheumatol; 2002; 31(2):66-71. PubMed ID: 12109649
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignancy in women with systemic lupus erythematosus.
Sweeney DM; Manzi S; Janosky J; Selvaggi KJ; Ferri W; Medsger TA; Ramsey-Goldman R
J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469
[TBL] [Abstract][Full Text] [Related]
11. Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
Kang KY; Kim HO; Yoon HS; Lee J; Lee WC; Ko HJ; Ju JH; Cho CS; Kim HY; Park SH
Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274
[TBL] [Abstract][Full Text] [Related]
12. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.
Chen YJ; Chang YT; Wang CB; Wu CY
Am J Med; 2010 Dec; 123(12):1150.e1-6. PubMed ID: 21183006
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus and the risk of malignancy.
Cibere J; Sibley J; Haga M
Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
[TBL] [Abstract][Full Text] [Related]
14. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
15. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden.
Nived O; Bengtsson A; Jönsen A; Sturfelt G; Olsson H
Lupus; 2001; 10(7):500-4. PubMed ID: 11480849
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's lymphoma in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
[TBL] [Abstract][Full Text] [Related]
17. Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE.
Rossi E; Catania G; Truini M; Ravetti GL; Grassia L; Marmont AM
Clin Exp Rheumatol; 2011; 29(3):555-9. PubMed ID: 21722503
[TBL] [Abstract][Full Text] [Related]
18. Malignancy in systemic lupus erythematosus: what have we learned?
Bernatsky S; Ramsey-Goldman R; Clarke AE
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):539-47. PubMed ID: 19591783
[TBL] [Abstract][Full Text] [Related]
19. Development of a lymphocytic lymphoma during immunosuppressive therapy with azathioprine for systemic lupus erythematosus with renal involvement induced by phenylbutazone.
Walden PA; Philalithis PE; Joekes AM; Bagshawe KD
Clin Nephrol; 1977 Jul; 8(1):317-20. PubMed ID: 577907
[TBL] [Abstract][Full Text] [Related]
20. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology.
Sankila R; Garwicz S; Olsen JH; Döllner H; Hertz H; Kreuger A; Langmark F; Lanning M; Möller T; Tulinius H
J Clin Oncol; 1996 May; 14(5):1442-6. PubMed ID: 8622057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]